Oxytocin and CBSST for People With Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

CBSST + Oxytocin

The oxytocin dose of 80 IU/day, will be administered in two divided doses: 40 IU in the morning and 40 IU in the evening. Oxytocin will be administered intranasally (10 puffs of the spray, 5 in each nostril at each administration). CBSST groups will occur for an hour twice/week. Nasal spray will be administered an hour prior to the CBSST group.

DRUG

CBSST + Placebo

Matching placebo spray will be administered intranasally (10 puffs of the spray, 5 in each nostril at each administration). CBSST groups will occur for an hour twice/week. Nasal spray will be administered an hour prior to the CBSST group.

Trial Locations (2)

21228

Maryland Psychiatric Research Center, Baltimore

92093

University of California, San Diego, San Diego

All Listed Sponsors
collaborator

University of California, San Diego

OTHER

lead

University of Maryland, Baltimore

OTHER

NCT01752712 - Oxytocin and CBSST for People With Schizophrenia | Biotech Hunter | Biotech Hunter